TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Bergentoft Pharma Consulting AB
Closing information (x1000 NOK)
| Closing information | 2022/12 | 2021/12 | 2020/12 |
| Turnover |
1,943
|
1,147
|
646 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
1,198
|
791
|
376 |
| EBITDA |
1,198
|
791
|
376 |
| Total assets |
2,779
|
1,657
|
1,090 |
| Current assets |
1,833
|
1,657
|
1,090 |
| Current liabilities |
725
|
399
|
221 |
| Equity capital |
1,909
|
1,172
|
788 |
| - share capital |
47
|
49
|
52 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Solvency |
68.7%
|
70.7%
|
72.3% |
| Turnover per employee |
1,943
|
1,147
|
646 |
| Profit as a percentage of turnover |
61.7%
|
69.0%
|
58.2% |
| Return on assets (ROA) |
43.1%
|
47.7%
|
34.5% |
| Current ratio |
252.8%
|
415.3%
|
493.2% |
| Return on equity (ROE) |
62.8%
|
67.5%
|
47.7% |
| Change turnover |
831
|
545
|
-375 |
| Change turnover % |
75%
|
91%
|
-37% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.